Following is one of the documents most requested by researchers using CAS electronic products.
|
CAS indexed 723 chemical substances from this document.
CAS subject entries for this document include: Proteins; Leukemia; Lymphoma; and 211 additional concepts. | |
CAPLUS COPYRIGHT 2002 ACS
| TITLE:
| Incensole and furanogermacrens and compounds in treatment for inhibiting neoplastic lesions and microorganisms |
| INVENTOR(S):
| Shanahan-Pendergast, Elisabeth |
| PATENT ASSIGNEE(S):
| Ire. |
| SOURCE:
| PCT Int. Appl., 68 pp. CODEN: PIXXD2 |
| LANGUAGE:
| English |
PATENT INFORMATION: PATENT NO. KIND DATE APPLICATION NO. DATE
--------------- ---- -------- --------------- --------
WO 2002053138 A2 20020711 WO 2002-IE1 20020102
WO 2002053138 A3 20020919
W: AE, AG, AT, AU, BB, BG, CA, CH, CN, CO, CU, CZ, LU, LV, MA, MD,
UA, UG, US, VN, YU, RU, TJ, TM
RW: GH, GM, KE, LS, MW, SD, SL, SZ, UG, AT, BE, CH, CY, DE, ES, FI,
ML, MR, NE, SN, TD, TG
ABSTRACT:
The invention discloses the use of incensole and/or furanogermacrens, derivs. metabolites and precursors thereof in the treatment of neoplasia, particularly resistant neoplasia and immundysregulatory disorders. These compds. can be administered alone or in combination with conventional chemotherapeutic, antiviral, antiparasite agents, radiation and/or surgery. Incensole and furanogermacren and their mixt. showed antitumor activity against various human carcinomas and melanomas and antimicrobial activity against Staphylococcus aureus and Enterococcus faecalis.
Updated 5/9/2007 10:20:37 AM
